Profiel
Scott L.
Young worked as a Principal at Genetics Institute LLC and Genzyme Corp.
He was also the Chief Operating Officer at Oncotelic Therapeutics, Inc. and Aldeyra Therapeutics, Inc. Additionally, he served as the Chief Operating Officer at Link Medicine Corp.
from 2006 to 2012.
Young received his undergraduate degree from the University of Massachusetts.
Eerdere bekende functies van Scott L. Young
Bedrijven | Functie | Einde |
---|---|---|
ALDEYRA THERAPEUTICS, INC. | Operationeel Directeur | 30-08-2016 |
ONCOTELIC THERAPEUTICS, INC. | Operationeel Directeur | 14-08-2006 |
University of Massachusetts | Corporate Officer/Principal | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Opleiding van Scott L. Young
University of Massachusetts | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
REPLIGEN CORPORATION | Health Technology |
ALDEYRA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |